Ciphergen Biosystems this week reported a 31-percent decline in its third quarter revenues, which it attributed to decreased sales of its Protein Chip mass spectrometry systems and BioSeptra process chromatography products.

Revenues for the quarter ending Sept. 30 totaled $11 million, down from $16 million during the same period last year, the company reported.

R&D expenses declined to $4.7 million from $5.4 million during the year-ago quarter.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports on the US Centers for Disease Control and Prevention's use of genetic approaches to study foodborne illnesses.

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.

A genomic analysis of modern and ancient maize reveals a complicated domestication history, according to Reuters.